CLN10 Disease
CLN10 disease is an extremely rare and devastating genetic neurodegenerative condition belonging to the neuronal ceroid lipofuscinoses, leading to severe brain cell loss and early mortality.
Overview
CLN10 disease is a severe form of neuronal ceroid lipofuscinosis (NCL), a group of disorders characterized by progressive decline in vision, motor function, and intellectual capability due to nervous system degeneration. NCL disorders are categorized by their specific genetic causes, with "CLN" designating neuronal ceroid lipofuscinosis followed by a subtype number.
Signs and Symptoms
The manifestations of CLN10 disease vary depending on the age of onset:
Congenital/Infantile Onset
Most frequently, CLN10 disease manifests immediately at birth or shortly thereafter, with indications that seizures may begin prenatally in the womb. Symptoms include:
- Severe muscle rigidity
- Respiratory failure
- Status epilepticus: Prolonged episodes of seizure activity lasting several minutes
- Marked microcephaly, with brains measuring less than half of normal volume
- Severe loss of brain cells within the cerebellum (responsible for coordinating movement) and the cerebral cortex (responsible for cognition and emotion)
- Severe deficiency in myelin, the protective fatty coating around nerve fibers
Infants with this severe congenital form typically survive only hours to weeks after delivery.
Late-Onset Form
Less commonly, symptoms do not appear until later, emerging between late infancy and adulthood. Manifestations develop progressively and include:
- Loss of balance and motor coordination (ataxia)
- Loss of speech
- Progressive intellectual and cognitive decline
- Vision loss
Individuals with late-onset CLN10 disease experience a shortened lifespan, determined largely by the age at which symptoms first manifest.
Causes
CLN10 disease is caused by mutations in the CTSD gene, which provides instructions for synthesizing an enzyme called cathepsin D. Cathepsin D functions within lysosomes—cellular compartments responsible for breaking down and recycling molecules—where it cuts apart specific proteins to degrade them, activate target molecules, or regulate cellular death.
- Congenital cases: Severe mutations cause a total absence of cathepsin D enzyme activity. Undigested proteins and fats accumulate abnormally within lysosomes, severely damaging nerve cells and leading to rapid neurological decline before or shortly after birth.
- Later-onset cases: Mutations allow partial enzyme function. Because some proteins and fats continue to be broken down, toxic lysosomal buildup progresses more slowly, delaying the onset of symptoms.
Inheritance
CLN10 disease is inherited in an autosomal recessive pattern. An individual must inherit two mutated copies of the CTSD gene (one from each parent) to be affected. Carrier parents holding one mutated copy typically show no symptoms of the disorder.
Frequency
The precise prevalence of CLN10 disease is unknown, though it is exceptionally rare, with at least 11 cases recorded in the medical literature.
Other Names
- Cathepsin D deficiency
- Cathepsin D deficient neuronal ceroid lipofuscinosis
- CLN10
- Congenital neuronal ceroid lipofuscinosis
- Neuronal ceroid lipofuscinosis 10
- Neuronal ceroid lipofuscinosis due to cathepsin D deficiency